Research Papers

25 of 3527 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Prognostic implications of HER2NEU-low in metastatic breast cancer.
Neubauer Z; Hasan S; Press RH; Chhabra AM; Fox J; Bakst R; Simone CB; Choi JI.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors…
Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions.
Javid H; Oryani MA; Rezagholinejad N; Esparham A; Tajaldini M; Karimi-Shahri M.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Efficacy of first-line treatment options beyond RET-TKIs in advanced RET-rearranged non-small cell lung cancer: A multi…
Ge Y; Li J; Gong W; Wang J; Wei X; Liu J; Wang S; Wang L; Sun H; Cheng Q; Sun Y; Dang Q; Sun Y; Gao A.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer.
Maeda O; Furune S; Kanda M; Miyata K; Shimizu D; Sugita S; Nishida K; Ando M; Kodera Y; Ando Y.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Registered
Application of computer-aided detection for NCCN-based follow-up recommendation in subsolid nodules: Effect on inter-ob…
Quanyang W; Lina Z; Yao H; Jiawei W; Wei T; Linlin Q; Zewei Z; Donghui H; Hongjia L; Shuluan C; Jiaxing Z; Shijun Z.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Hearing preservation after stereotactic radiosurgery for sporadic intracanalicular vestibular schwannomas classified as…
Kang H; Ji SY; Kim CY; Koo JW; Song JJ; Choi BY; Hwang K; Han JH.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Patient's experiences of coughing after lung cancer surgery: A multicenter qualitative study.
Zhou X; Lei C; Wei X; Dai W; Xu W; Ao Y; Li X; Qiao G; Shi Q.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing trea…
Huang SY; Su PJ; Lin CT; Kuo MC; Chen YH; Wu CC; Luo HL; Chen CH; Chou CC; Huang CC; Kuo CW; Su YL.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving …
Weng G; Huang J; An N; Zhang Y; Yu G; Sun Z; Lin D; Deng L; Liang X; Xiao J; Zhang H; Guo Z; He X; Jin H; Liu Q; Du X.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells.
Lebon D; Collet L; Djordjevic S; Gomila C; Ouled-Haddou H; Platon J; Demont Y; Marolleau JP; Caulier A; Garçon L.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Feasible diet and circadian interventions reduce in vivo progression of FLT3-ITD-positive acute myeloid leukemia.
Rodriguez M; Fekry B; Murphy B; Figueroa M; Cheng T; Raber M; Wartenberg L; Bell D; Triche L; Crawford K; Ma H; Allton K; Ahmed R; Tran J; Ranieri C; Konopleva M; Barton M; Nunez C; Eckel-Mahan K; Chandra J.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic…
Houvenaeghel G; de Nonneville A; Cohen M; Sabiani L; Buttarelli M; Charaffe E; Jalaguier A; Bannier M; Tallet A; Viret F; Gonçalves A.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
LGBTQ+ inequity in crowdfunding cancer costs: The influence of online reach and LGBTQ+ state policy.
Waters AR; Easterly CW; Turner C; Ghazal L; Tovar I; Mulvaney M; Poquadeck M; Rains SA; Cloyes KG; Kirchhoff AC; Kent EE; Warner EL.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The incremental healthcare cost associated with cancer in Belgium: A registry-based data analysis.
Gorasso V; Vandevijvere S; Van der Heyden J; Pelgrims I; Hilderink H; Nusselder W; Demoury C; Schmidt M; Vansteelandt S; De Smedt D; Devleesschauwer B.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/…
Agelaki S; Boukovinas I; Athanasiadis I; Trimis G; Dimitriadis I; Poughias L; Morais E; Sabale U; Bencina G; Athanasopoulos C.
Cancer Med (Unknown)
Published: 2024
5/6 Transparent
Data Registered Funding Declared
Retinoblastoma treatment in a Brazilian population. Presentation and long-term results.
Bonanomi MTBC; de Almeida MTA; Hollaender MA; Bonanomi RC; Monteiro MLR.
Cancer Med (Unknown)
Published: 2024
1/6 Transparent
Neurocognitive and psychosocial outcomes in survivors of childhood leukemia with Down syndrome.
Gandy K; Hall L; Krull KR; Esbensen AJ; Rubnitz J; Jacola LM.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Disparities in care of older adults of color with cancer: A narrative review.
Dotan E; Lynch SM; Ryan JC; Mitchell EP.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients.
Shimasaki Y; Miyoshi H; Kawamoto K; Yoshida N; Mishina T; Nakashima K; Imamoto T; Sugio T; Yanagida E; Kato T; Yamada K; Takeuchi M; Suzuki T; Moritsubo M; Furuta T; Imaizumi Y; Takizawa J; Kato K; Suzumiya J; Suzuki R; Ohshima K.
Cancer Med (Unknown)
Published: 2024
2/6 Transparent
Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in …
Yan M; Yao J; Zhang X; Xu D; Yang C.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank c…
Christakoudi S; Tsilidis KK; Evangelou E; Riboli E.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population-based anal…
He LF; Zhang JD; Zhu TF; Zhao PC; Mou P; Tang SY.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologn…
Kast K; Rhiem K; Larsen M; Wappenschmidt B; Schmutzler R.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prior Clinico-Radiological Features Informed Multi-Modal MR Images Convolution Neural Network: A novel deep learning fr…
Zheng H; Jian L; Li L; Liu W; Chen W.
Cancer Med (Unknown)
Published: 2024
2/6 Transparent